Background: In the general population, low IGF1 has been associated with higher prevalence of cardiovascular disease and mortality. Objective: To investigate the relationships between IGF1 levels, blood pressure (BP), and glucose tolerance (GT). Subjects: Four-hundred and four subjects (200 men aged 18-80 years). Exclusion criteria: personal history of pituitary or cardiovascular diseases; previous or current treatments with drugs interfering with BP, GT, or lipids, corticosteroids (> 2 weeks), estrogens, or testosterone (> 12 weeks); smoking of > 15 cigarettes/day and alcohol abuse (> 3 glasses of wine/day). Results: Two hundred and ninety-six had normal BP (73.3%), 86 had mild (21.3%), and 22 had severe (5.4%) hypertension; 322 had normal GT (NGT (79.7%)), 53 had impaired glucose tolerance (IGT (13.1%)), 29 had diabetes mellitus (7.2%). Normotensive subjects had significantly higher IGF1 levels (0.11±0.94 SDS) than those with mild (-0.62±1.16 SDS, P<0.0001) or severe (-1.01±1.07 SDS, P<0.0001) hypertension. IGF1 SDS (t=-3.41, P=0.001) independently predicted systolic and diastolic BP (t=-2.77, P=0.006) values. NGT subjects had significantly higher IGF1 levels (0.13±0.90 SDS) than those with IGT (-0.86±1.14 SDS, P<0.0001) or diabetes mellitus (-1.31±1.13 SDS, P<0.0001). IGF1 SDS independently predicted fasting glucose (t=-3.49, P=0.0005) and homeostatic model assessment (HOMA)-R (t=-2.15, P=0.033) but not insulin (t=-1.92, P=0.055) and HOMA-β (t=-0.19, P=0.85). Conclusion: IGF1 levels in the low normal range are associated with hypertension and diabetes in subjects without pituitary and cardiovascular diseases.

Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects / A. Colao, C. Di Somma, T. Cascella, R. Pivonello, G. Vitale, L.F.S. Grasso, G. Lombardi, S. Savastano. - In: EUROPEAN JOURNAL OF ENDOCRINOLOGY. - ISSN 0804-4643. - 159:4(2008 Oct), pp. 389-397.

Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects

G. Vitale;
2008

Abstract

Background: In the general population, low IGF1 has been associated with higher prevalence of cardiovascular disease and mortality. Objective: To investigate the relationships between IGF1 levels, blood pressure (BP), and glucose tolerance (GT). Subjects: Four-hundred and four subjects (200 men aged 18-80 years). Exclusion criteria: personal history of pituitary or cardiovascular diseases; previous or current treatments with drugs interfering with BP, GT, or lipids, corticosteroids (> 2 weeks), estrogens, or testosterone (> 12 weeks); smoking of > 15 cigarettes/day and alcohol abuse (> 3 glasses of wine/day). Results: Two hundred and ninety-six had normal BP (73.3%), 86 had mild (21.3%), and 22 had severe (5.4%) hypertension; 322 had normal GT (NGT (79.7%)), 53 had impaired glucose tolerance (IGT (13.1%)), 29 had diabetes mellitus (7.2%). Normotensive subjects had significantly higher IGF1 levels (0.11±0.94 SDS) than those with mild (-0.62±1.16 SDS, P<0.0001) or severe (-1.01±1.07 SDS, P<0.0001) hypertension. IGF1 SDS (t=-3.41, P=0.001) independently predicted systolic and diastolic BP (t=-2.77, P=0.006) values. NGT subjects had significantly higher IGF1 levels (0.13±0.90 SDS) than those with IGT (-0.86±1.14 SDS, P<0.0001) or diabetes mellitus (-1.31±1.13 SDS, P<0.0001). IGF1 SDS independently predicted fasting glucose (t=-3.49, P=0.0005) and homeostatic model assessment (HOMA)-R (t=-2.15, P=0.033) but not insulin (t=-1.92, P=0.055) and HOMA-β (t=-0.19, P=0.85). Conclusion: IGF1 levels in the low normal range are associated with hypertension and diabetes in subjects without pituitary and cardiovascular diseases.
Settore MED/13 - Endocrinologia
ott-2008
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/55121
Citazioni
  • ???jsp.display-item.citation.pmc??? 30
  • Scopus 90
  • ???jsp.display-item.citation.isi??? 83
social impact